J Korean Med Sci.  2022 Dec;37(50):e357. 10.3346/jkms.2022.37.e357.

Letter to the Editor: There Is No Indication for Treating Long COVID Vaccination Syndrome With Colchicine

• Finsterer J

• KMID: 2537055
• DOI: http://doi.org/10.3346/jkms.2022.37.e357

Reference

1. Lee HJ, Jeong YJ, Kim YJ, Kim SH. Multisystem inflammatory syndrome in an adult following COVID-19 mRNA vaccination: successful treatment with medium-dose steroids and colchicine. J Korean Med Sci. 2022; 37(41):e299. PMID: 36281487.

2. Finsterer J. Long post-COVID vaccination syndrome. Brain Nerves. 2022; (online) https://www.oatext.com/long-post-cOVID-vaccination-syndrome.php.

3. Abudalou M, Mohamed AS, Vega EA, Al Sbihi A. Colchicine-induced rhabdomyolysis: a review of 83 cases. BMJ Case Rep. 2021; 14(7):e241977.

4. Francis L, Bonilla E, Soforo E, Neupane H, Nakhla H, Fuller C, et al. Fatal toxic myopathy attributed to propofol, methylprednisolone, and cyclosporine after prior exposure to colchicine and simvastatin. Clin Rheumatol. 2008; 27(1):129–131. PMID: 17628739.

5. Ehikhametalor K, Deans-Minott J, Duncan JP. Multisystem inflammatory syndrome in adults (MIS-A) after COVID-19 infection and recent vaccination with recombinant adenoviral vector encoding the spike protein antigen of SARS-CoV-2 (ChAdOx1 nCoV-19, Vaxzevria). J Intensive Care Med. 2023; 38(2):232–237. PMID: 35979616.